RAD6-mediated epigenetic reprogramming contributes to therapy-induced chemo-resistance in ovarian cancer.

被引：0
|
作者：
Omy, Tasmin Rahman [1 ]
Jonnalagadda, Shirisha [1 ]
Reedy, Mark [1 ]
Palle, Komaraiah [1 ]
机构：
[1] Texas Tech Univ, Hlth Sci Ctr, Lubbock, TX 79430 USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2111
引用
收藏
页数：1
相关论文
共 15 条
  • [1] Epigenetic regulation of glycosylation and the impact on chemo-resistance in breast and ovarian cancer
    Greville, Gordon
    McCann, Amanda
    Rudd, Pauline M.
    Saldova, Radka
    EPIGENETICS, 2016, 11 (12) : 845 - 857
  • [2] Identification of the specific epigenetic alterations associated with chemo-resistance via reprogramming of cancer cells
    Kim, Jong Joo
    Rai, Rajani
    MEDICAL HYPOTHESES, 2015, 85 (06) : 710 - 714
  • [3] Therapy-induced developmental reprogramming of prostate cancer cells and acquired therapy resistance
    Nouri, Mannan
    Caradec, Josselin
    Lubik, Amy Anne
    Li, Na
    Hollier, Brett G.
    Takhar, Mandeep
    Altimirano-Dimas, Manuel
    Chen, Mengqian
    Roshan-Moniri, Mani
    Butler, Miriam
    Lehman, Melanie
    Bishop, Jennifer
    Truong, Sarah
    Huang, Shih-Chieh
    Cochrane, Dawn
    Cox, Michael
    Collins, Colin
    Gleave, Martin
    Erho, Nicholas
    Alshalafa, Mohamed
    Davicioni, Elai
    Nelson, Colleen
    Gregory-Evans, Sheryl
    Karnes, R. Jeffrey
    Jenkins, Robert B.
    Klein, Eric A.
    Buttyan, Ralph
    ONCOTARGET, 2017, 8 (12) : 18949 - 18967
  • [4] Rad6/Rad18-Mediated Ubiquitin Signaling Integrates DNA Repair and Stem Cell Signaling and Contributes to Poor Outcomes in Ovarian Cancer.
    Spencer, S. M.
    Somasagara, R.
    Tripathi, K.
    Rocconi, R. P.
    Palle, K.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2016, 57 : S71 - S71
  • [5] CCL2 and interleukin-6 regulate EMT-mediated chemo-resistance in prostate cancer
    Zou, Chunlin
    Lu, Yi
    Mizokami, Atsushi
    Keller, Evan T.
    Pienta, Kenneth J.
    Zhang, Jian
    CANCER RESEARCH, 2012, 72
  • [6] RAD6-mediated DNA damage responses cross-talk with oncogenic signaling to promote acquired chemoresistance and malignant properties in ovarian cancer
    Palle, K.
    Somasagara, R. R.
    Spencer, S. M.
    Tripathi, K.
    Clark, D. W.
    Mani, C.
    da Silva, Madeira L.
    Scalici, J.
    Kothayer, H.
    Westwell, A. D.
    Rocconi, R. P.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2017, 58 : S80 - S80
  • [7] ATF6-Mediated Signaling Contributes to PARP Inhibitor Resistance in Ovarian Cancer
    McMellen, Alexandra
    Yamamoto, Tomomi M.
    Qamar, Lubna
    Sanders, Brooke E.
    Nguyen, Lily L.
    Chavez, Daniela Ortiz
    Bapat, Jaidev
    Berning, Amber
    Post, Miriam D.
    Johnson, Joshua
    Behbakht, Kian
    Nurmemmedov, Elmar
    Chuong, Edward B.
    Bitler, Benjamin G.
    MOLECULAR CANCER RESEARCH, 2023, 21 (01) : 3 - 13
  • [8] The glycosyltransferase ST6Gal-I is enriched in cancer stem-like cells in colorectal carcinoma and contributes to their chemo-resistance
    Cui, H.
    Yang, S.
    Jiang, Y.
    Li, C.
    Zhao, Y.
    Shi, Y.
    Hao, Y.
    Qian, F.
    Tang, B.
    Yu, P.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (09): : 1175 - 1184
  • [9] The glycosyltransferase ST6Gal-I is enriched in cancer stem-like cells in colorectal carcinoma and contributes to their chemo-resistance
    H. Cui
    S. Yang
    Y. Jiang
    C. Li
    Y. Zhao
    Y. Shi
    Y. Hao
    F. Qian
    B. Tang
    P. Yu
    Clinical and Translational Oncology, 2018, 20 : 1175 - 1184
  • [10] Targeting slug-mediated non-canonical activation of c-Met to overcome chemo-resistance in metastatic ovarian cancer cells
    Linlin Chang
    Yan Hu
    Yingying Fu
    Tianyi Zhou
    Jun You
    Jiamin Du
    Lin Zheng
    Ji Cao
    Meidan Ying
    Xiaoyang Dai
    Dan Su
    Qiaojun He
    Hong Zhu
    Bo Yang
    Acta Pharmaceutica Sinica B, 2019, 9 (03) : 484 - 495
12